Nevan C Elam's Net Worth
$4.81 Million
Who is Nevan C Elam?
Nevan C Elam has an estimated net worth of $4.81 Million. This is based on reported shares across multiple companies, which include NEKTAR THERAPEUTICS, Rezolute, Inc., Savara Inc, and Peak Bio, Inc..
SEC CIK
Nevan C Elam's CIK is 0001314773
Past Insider Trading and Trends
2021 was Nevan C Elam's most active year for acquiring shares with 5 total transactions. Nevan C Elam's most active month to acquire stocks was the month of November. 2021 was Nevan C Elam's most active year for disposing of shares, totalling 8 transactions. Nevan C Elam's most active month to dispose stocks was the month of May. 2005 saw Nevan C Elam paying a total of $2,977,600.00 for 160,000 shares, this is the most they've acquired in one year. In 2007 Nevan C Elam cashed out on 1,400 shares for a total of $14.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $0.7001
SVP & Head Pulmonary Bus
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
∞
| 1.4K |
$0.01 | $14.00 | 1.4K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rezolute, Inc. (RZLT) Snapshot price: $0.9501
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +177.49% | 5K |
$1.68 | $8,400.00 | 7.82K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
| -100.00% | -842.95K |
—
|
—
|
0
|
Feb 9 - Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
| +26.44% | 1.06M |
$0.26 | $275,000.00 | 5.06M |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Savara Inc (SVRA) Snapshot price: $4.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -64.05% | -40.09K |
$3.01 | -$372,569.88 | 22.5K |
Dec 28
| |||
Form 4
| +56.13% | 22.5K |
—
|
—
| 62.59K |
Dec 14
| |||
Form 4
| +37.07% | 10.84K |
$0.82 | $8,889.62 | 40.09K |
Dec 11
| |||
Form 4
| +4.17% | 1.17K |
$0.65 | $761.80 | 29.24K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
| +4.36% | 1.17K |
$0.55 | $644.60 | 28.07K |
Dec 6
| |||
Form 4
| +9.30% | 2.29K |
$0.52 | $1,189.76 | 26.9K |
Aug 18
| |||
Form 4
| +13.51% | 2.93K |
$0.52 | $1,523.60 | 24.61K |
Dec 15 - Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
∞
| 21.68K |
$0.19 | $4,119.58 | 21.68K |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Peak Bio, Inc. (PKBO) Snapshot price: $0.0377
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||